LYMPHATIC DISEASES
Clinical trials for LYMPHATIC DISEASES explained in plain language.
Never miss a new study
Get alerted when new LYMPHATIC DISEASES trials appear
Sign up with your email to follow new studies for LYMPHATIC DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at Hard-to-Treat lymphomas
Disease control OngoingThis study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has come back or not responded to other therapies. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells carrying a protein …
Matched conditions: LYMPHATIC DISEASES
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
Engineered immune cells get a navigation system to hunt down lymphoma
Disease control OngoingThis early-phase study tests a new treatment for people with certain types of lymphoma that have not responded to standard therapy or have returned. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack cancer cells, plus a…
Matched conditions: LYMPHATIC DISEASES
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
Engineered T-Cells with kill switch offer new hope for lymphoma patients
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy for people with B-cell lymphoma that has come back or not responded to treatment. The T-cells are modified to target cancer cells and include a safety switch that can be turned on to reduce severe side effects. The goa…
Matched conditions: LYMPHATIC DISEASES
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 10:07 UTC